191 related articles for article (PubMed ID: 30051542)
1. Survival patterns and cancer determinants in families with myotonic dystrophy type 1.
Best AF; Hilbert JE; Wood L; Martens WB; Nikolenko N; Marini-Bettolo C; Lochmüller H; Rosenberg PS; Moxley RT; Greene MH; Gadalla SM
Eur J Neurol; 2019 Jan; 26(1):58-65. PubMed ID: 30051542
[TBL] [Abstract][Full Text] [Related]
2. Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink.
Wang Y; Pfeiffer RM; Alsaggaf R; Meeraus W; Gage JC; Anderson LA; Bremer RC; Nikolenko N; Lochmuller H; Greene MH; Gadalla SM
Int J Cancer; 2018 Mar; 142(6):1174-1181. PubMed ID: 29114849
[TBL] [Abstract][Full Text] [Related]
3. Diabetes, metformin and cancer risk in myotonic dystrophy type I.
Alsaggaf R; Pfeiffer RM; Wang Y; St George DMM; Zhan M; Wagner KR; Amr S; Greene MH; Gadalla SM
Int J Cancer; 2020 Aug; 147(3):785-792. PubMed ID: 31749144
[TBL] [Abstract][Full Text] [Related]
4. Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial.
van Engelen B;
Trials; 2015 May; 16():224. PubMed ID: 26002596
[TBL] [Abstract][Full Text] [Related]
5. The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research.
Wood L; Cordts I; Atalaia A; Marini-Bettolo C; Maddison P; Phillips M; Roberts M; Rogers M; Hammans S; Straub V; Petty R; Orrell R; Monckton DG; Nikolenko N; Jimenez-Moreno AC; Thompson R; Hilton-Jones D; Turner C; Lochmüller H
J Neurol; 2017 May; 264(5):979-988. PubMed ID: 28397002
[TBL] [Abstract][Full Text] [Related]
6. Correlates of tumor development in patients with myotonic dystrophy.
Das M; Moxley RT; Hilbert JE; Martens WB; Letren L; Greene MH; Gadalla SM
J Neurol; 2012 Oct; 259(10):2161-6. PubMed ID: 22619053
[TBL] [Abstract][Full Text] [Related]
7. Increased cancer risks in myotonic dystrophy.
Win AK; Perattur PG; Pulido JS; Pulido CM; Lindor NM
Mayo Clin Proc; 2012 Feb; 87(2):130-5. PubMed ID: 22237010
[TBL] [Abstract][Full Text] [Related]
8. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
[TBL] [Abstract][Full Text] [Related]
9. Familial clustering of muscular and cardiac involvement in myotonic dystrophy type 1.
Groh WJ; Lowe MR; Simmons Z; Bhakta D; Pascuzzi RM
Muscle Nerve; 2005 Jun; 31(6):719-24. PubMed ID: 15770673
[TBL] [Abstract][Full Text] [Related]
10. Survival and mortality of myotonic dystrophy type 1 (Steinert's disease) in the population of Belgrade.
Mladenovic J; Pekmezovic T; Todorovic S; Rakocevic-Stojanovic V; Savic D; Romac S; Apostolski S
Eur J Neurol; 2006 May; 13(5):451-4. PubMed ID: 16722967
[TBL] [Abstract][Full Text] [Related]
11. Benign tumors in myotonic dystrophy type I target disease-related cancer sites.
Alsaggaf R; St George DMM; Zhan M; Pfeiffer RM; Wang Y; Anderson LA; Liu Z; Koshiol J; Bauer AJ; Wagner KR; Greene MH; Amr S; Gadalla SM
Ann Clin Transl Neurol; 2019 Aug; 6(8):1510-1518. PubMed ID: 31402615
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation.
Fernández-Torrón R; García-Puga M; Emparanza JI; Maneiro M; Cobo AM; Poza JJ; Espinal JB; Zulaica M; Ruiz I; Martorell L; Otaegui D; Matheu A; López de Munain A
Neurology; 2016 Sep; 87(12):1250-7. PubMed ID: 27558368
[TBL] [Abstract][Full Text] [Related]
14. Metabolic complications in myotonic dystrophy type 1: A cross-sectional survey using the National Registry of Japan.
Hama M; Horie R; Kubota T; Matsumura T; Kimura E; Nakamura H; Takahashi MP; Takada H
J Neurol Sci; 2021 Aug; 427():117511. PubMed ID: 34082146
[TBL] [Abstract][Full Text] [Related]
15. Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1.
Wahbi K; Algalarrondo V; Bécane HM; Fressart V; Beldjord C; Azibi K; Lazarus A; Berber N; Radvanyi-Hoffman H; Stojkovic T; Béhin A; Laforêt P; Eymard B; Hatem S; Duboc D
Arch Cardiovasc Dis; 2013 Dec; 106(12):635-43. PubMed ID: 24140416
[TBL] [Abstract][Full Text] [Related]
16. Family communication following a diagnosis of myotonic dystrophy: To tell or not to tell?
Taylor S; Rodrigues M; Poke G; Wake S; McEwen A
J Genet Couns; 2019 Oct; 28(5):1029-1041. PubMed ID: 31385417
[TBL] [Abstract][Full Text] [Related]
17. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
Bienias P; Łusakowska A; Ciurzyński M; Rymarczyk Z; Irzyk K; Kurnicka K; Kamińska A; Pruszczyk P
Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
[TBL] [Abstract][Full Text] [Related]
18. Frequency and type of cancers in myotonic dystrophy: A retrospective cross-sectional study.
D'Ambrosio ES; Chuang K; David WS; Amato AA; Gonzalez-Perez P
Muscle Nerve; 2023 Aug; 68(2):142-148. PubMed ID: 36790141
[TBL] [Abstract][Full Text] [Related]
19. Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy.
Gadalla SM; Hilbert JE; Martens WB; Givens S; Moxley RT; Greene MH
Eur J Neurol; 2017 May; 24(5):713-718. PubMed ID: 28317292
[TBL] [Abstract][Full Text] [Related]
20. Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry.
Chong-Nguyen C; Wahbi K; Algalarrondo V; Bécane HM; Radvanyi-Hoffman H; Arnaud P; Furling D; Lazarus A; Bassez G; Béhin A; Fayssoil A; Laforêt P; Stojkovic T; Eymard B; Duboc D
Circ Cardiovasc Genet; 2017 Jun; 10(3):. PubMed ID: 28611030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
